Abstract
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have